Moreover, nuclear REDD1 positive was significantly lower in ovarian cancer specimens (18.8%, 43/229) than in normal ovarian surface epithelial tissue and fallopian tube tissue specimens (50%, 9/18) and borderline tumor tissue specimens (62.5%, 15/24) (P = 0.000, Table 1). This evidence concerns the gene DDIT4 and ovarian carcinoma.